New Zealand markets close in 2 hours 45 minutes

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
61.43-2.88 (-4.48%)
At close: 04:00PM EDT
60.50 -0.93 (-1.51%)
After hours: 07:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.16B
Enterprise value 3.01B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.14
Price/book (mrq)11.95
Enterprise value/revenue 19.27
Enterprise value/EBITDA -31.70

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3130.17%
S&P500 52-week change 324.49%
52-week high 365.00
52-week low 324.83
50-day moving average 350.24
200-day moving average 340.26

Share statistics

Avg vol (3-month) 3561.52k
Avg vol (10-day) 3846.38k
Shares outstanding 551.42M
Implied shares outstanding 653.88M
Float 844.35M
% held by insiders 13.56%
% held by institutions 191.07%
Shares short (15 Apr 2024) 45.36M
Short ratio (15 Apr 2024) 411.94
Short % of float (15 Apr 2024) 414.36%
Short % of shares outstanding (15 Apr 2024) 410.42%
Shares short (prior month 15 Mar 2024) 44.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -66.12%
Operating margin (ttm)-62.08%

Management effectiveness

Return on assets (ttm)-20.31%
Return on equity (ttm)-47.29%

Income statement

Revenue (ttm)156.33M
Revenue per share (ttm)3.21
Quarterly revenue growth (yoy)82.50%
Gross profit (ttm)N/A
EBITDA -104.24M
Net income avi to common (ttm)-103.37M
Diluted EPS (ttm)-2.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)225.58M
Total cash per share (mrq)4.39
Total debt (mrq)83.3M
Total debt/equity (mrq)31.55%
Current ratio (mrq)8.52
Book value per share (mrq)5.14

Cash flow statement

Operating cash flow (ttm)-104.36M
Levered free cash flow (ttm)-99.36M